Chief of Staff commends Goldbod staff during working visit

Chief of Staff at the Presidency, Julius Debrah, has paid a working visit to the Ghana Gold Board (GOLDBOD) as part of efforts to familiarise himself with the institution’s operations and express the government’s appreciation for its contributions to the country’s mineral sector.
During the visit, Mr. Debrah commended the management and staff of GOLDBOD for their dedication and hard work in regulating and promoting responsible gold trade in Ghana.
He acknowledged the critical role the agency plays in ensuring transparency and accountability within the gold industry.
“I want to thank all of you for your continued service to the nation. Your efforts in safeguarding Ghana’s gold resources are commendable, and I wish you the very best in your work going forward,” the Chief of Staff stated.
The visit afforded him the opportunity to engage directly with staff, listen to their concerns, and discuss ways to enhance the agency’s efficiency and impact.
Mr. Debrah reiterated the government’s commitment to supporting GOLDBOD in fulfilling its mandate, assuring the team that their work remains crucial to Ghana’s economic development and international reputation in the gold trade.
Source: Classfmonline.com/Cecil Mensah
Trending News
Parliamentary re-run at Ablekuma North: Police assure of 'adequate security' for Fri
07:58Accra London Health Centre to revolutionise women’s healthcare in Ghana
03:01Akwatia MP Ernest Kumi dies
13:19Akufo-Addo/Bawumia gov't’s major gains in TVET transformation highlighted
20:36Finance Minister calls for ruthless action against gold smugglers
02:22Credit tug-of-war over Eban-Akoma oil discoveries
13:11Ablekuma North: Someday others will fly because you walked – Akosua Manu encourages Akua Afriyie amid EC re-run decision
20:22NDC’s Godwin Tameklo welcomes NPP boycott of Ablekuma North re-run
01:55Goldboard task force to intensify crackdown on smuggling: "No room for looting our natural wealth" – Sammy Gyamfi declares
12:46GFZA CEO backs new pharmaceutical venture under Free Zones Scheme
15:35